Aptevo Therapeutics Inc (NASDAQ:APVO) has a beta value of 5.06 and has seen 2.22 million shares traded in the last trading session. The company, currently valued at $2.44M, closed the last trade at $0.28 per share which meant it gained $0.03 on the day or 13.71% during that session. The APVO stock price is -4582.14% off its 52-week high price of $13.11 and 50.0% above the 52-week low of $0.14. If we look at the company’s 10-day average daily trading volume, we find that it stood at 32.74 million shares traded. The 3-month trading volume is 6.08 million shares.
Aptevo Therapeutics Inc (NASDAQ:APVO) trade information
Sporting 13.71% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the APVO stock price touched $0.28 or saw a rise of 20.75%. Year-to-date, Aptevo Therapeutics Inc shares have moved -96.46%, while the 5-day performance has seen it change 18.69%. Over the past 30 days, the shares of Aptevo Therapeutics Inc (NASDAQ:APVO) have changed 66.77%. Short interest in the company has seen 0.15 million shares shorted with days to cover at 0.06.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aptevo Therapeutics Inc (APVO) estimates and forecasts
Figures show that Aptevo Therapeutics Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -74.59% over the past 6 months, with this year growth rate of 95.56%, compared to 17.50% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 46.80% over the past 5 years.
APVO Dividends
Aptevo Therapeutics Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Aptevo Therapeutics Inc (NASDAQ:APVO)’s Major holders
Insiders own 0.04% of the company shares, while shares held by institutions stand at 14.46% with a share float percentage of 14.47%. Investors are also buoyed by the number of investors in a company, with Aptevo Therapeutics Inc having a total of 19.0 institutions that hold shares in the company.
